Q3 2023
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IMVT | New | IMMUNOVANT INC | $69,807,263 | – | 1,818,371 | – | 24.57% | – |
| ARGX | Sell | ARGENX SEsponsored adr | $22,425,702 | -78.9% | 45,615 | -83.3% | 7.89% | -54.7% |
| TGTX | Exit | TG THERAPEUTICS INC | $0 | – | -9,278,439 | – | -37.68% | – |
Q2 2023
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AMAM | New | AMBRX BIOPHARMA INCsponsored ads | $274,694,949 | – | 16,688,636 | – | 44.91% | – |
| TGTX | New | TG THERAPEUTICS INC | $230,476,425 | – | 9,278,439 | – | 37.68% | – |
| ARGX | New | ARGENX SEsponsored adr | $106,529,967 | – | 273,343 | – | 17.42% | – |
Q4 2022
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KRTX | Exit | KARUNA THERAPEUTICS INC | $0 | – | -77,768 | – | -26.34% | – |
| Exit | VENTYX BIOSCIENCES INC | $0 | – | -1,401,123 | – | -73.66% | – |
Q3 2022
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | VENTYX BIOSCIENCES INC | $48,913,000 | – | 1,401,123 | – | 73.66% | – | |
| KRTX | New | KARUNA THERAPEUTICS INC | $17,492,000 | – | 77,768 | – | 26.34% | – |
| AZN | Exit | ASTRAZENECA PLCsponsored adr | $0 | – | -2,849,109 | – | -100.00% | – |
Q2 2022
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AZN | New | ASTRAZENECA PLCsponsored adr | $188,241,000 | – | 2,849,109 | – | 100.00% | – |
Q4 2021
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AVTE | Exit | AEROVATE THERAPEUTICS INC | $0 | – | -12,484 | – | -0.05% | – |
| FULC | Exit | FULCRUM THERAPEUTICS INC | $0 | – | -33,997 | – | -0.18% | – |
| VERV | Exit | VERVE THERAPEUTICS INC | $0 | – | -27,397 | – | -0.24% | – |
| VIR | Exit | VIR BIOTECHNOLOGY INC | $0 | – | -45,311 | – | -0.36% | – |
| ACRS | Exit | ACLARIS THERAPEUTICS INC | $0 | – | -159,393 | – | -0.53% | – |
| Exit | ADAGIO THERAPEUTICS INC | $0 | – | -86,528 | – | -0.67% | – | |
| BBIO | Exit | BRIDGEBIO PHARMA INC | $0 | – | -253,692 | – | -2.19% | – |
| INBX | Exit | INHIBRX INC | $0 | – | -542,586 | – | -3.33% | – |
| FATE | Exit | FATE THERAPEUTICS INC | $0 | – | -353,250 | – | -3.85% | – |
| BNTX | Exit | BIONTECH SEsponsored ads | $0 | – | -132,932 | – | -6.68% | – |
| NTLA | Exit | INTELLIA THERAPEUTICS INC | $0 | – | -752,024 | – | -18.57% | – |
| XLRN | Exit | ACCELERON PHARMA INC | $0 | – | -2,000,000 | – | -63.36% | – |
Q3 2021
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| XLRN | Buy | ACCELERON PHARMA INC | $344,200,000 | +55.8% | 2,000,000 | +13.6% | 63.36% | +77.8% |
| NTLA | Sell | INTELLIA THERAPEUTICS INC | $100,884,000 | -66.5% | 752,024 | -59.6% | 18.57% | -61.8% |
| BNTX | New | BIONTECH SEsponsored ads | $36,289,000 | – | 132,932 | – | 6.68% | – |
| FATE | Buy | FATE THERAPEUTICS INC | $20,937,000 | -28.2% | 353,250 | +5.2% | 3.85% | -18.1% |
| INBX | Buy | INHIBRX INC | $18,074,000 | +191.3% | 542,586 | +140.6% | 3.33% | +232.4% |
| BBIO | Sell | BRIDGEBIO PHARMA INC | $11,891,000 | -42.1% | 253,692 | -24.7% | 2.19% | -33.9% |
| New | ADAGIO THERAPEUTICS INC | $3,655,000 | – | 86,528 | – | 0.67% | – | |
| ACRS | Sell | ACLARIS THERAPEUTICS INC | $2,869,000 | -34.6% | 159,393 | -36.2% | 0.53% | -25.4% |
| VIR | New | VIR BIOTECHNOLOGY INC | $1,972,000 | – | 45,311 | – | 0.36% | – |
| VERV | Sell | VERVE THERAPEUTICS INC | $1,288,000 | -79.2% | 27,397 | -73.4% | 0.24% | -76.3% |
| FULC | New | FULCRUM THERAPEUTICS INC | $959,000 | – | 33,997 | – | 0.18% | – |
| AVTE | New | AEROVATE THERAPEUTICS INC | $262,000 | – | 12,484 | – | 0.05% | – |
| GBIO | Exit | GENERATION BIO CO | $0 | – | -10,738 | – | -0.05% | – |
| RLAY | Exit | RELAY THERAPEUTICS INC | $0 | – | -119,775 | – | -0.71% | – |
| KROS | Exit | KEROS THERAPEUTICS INC | $0 | – | -104,186 | – | -0.71% | – |
| EPIX | Exit | ESSA PHARMA INC | $0 | – | -208,524 | – | -0.96% | – |
| BEAM | Exit | BEAM THERAPEUTICS INC | $0 | – | -126,985 | – | -2.64% | – |
Q2 2021
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NTLA | New | INTELLIA THERAPEUTICS INC | $301,141,000 | – | 1,859,926 | – | 48.58% | – |
| XLRN | New | ACCELERON PHARMA INC | $220,906,000 | – | 1,760,346 | – | 35.63% | – |
| FATE | New | FATE THERAPEUTICS INC | $29,154,000 | – | 335,918 | – | 4.70% | – |
| BBIO | New | BRIDGEBIO PHARMA INC | $20,532,000 | – | 336,817 | – | 3.31% | – |
| BEAM | New | BEAM THERAPEUTICS INC | $16,344,000 | – | 126,985 | – | 2.64% | – |
| VERV | New | VERVE THERAPEUTICS INC | $6,207,000 | – | 103,013 | – | 1.00% | – |
| INBX | New | INHIBRX INC | $6,205,000 | – | 225,480 | – | 1.00% | – |
| EPIX | New | ESSA PHARMA INC | $5,958,000 | – | 208,524 | – | 0.96% | – |
| KROS | New | KEROS THERAPEUTICS INC | $4,425,000 | – | 104,186 | – | 0.71% | – |
| ACRS | New | ACLARIS THERAPEUTICS INC | $4,390,000 | – | 250,000 | – | 0.71% | – |
| RLAY | New | RELAY THERAPEUTICS INC | $4,383,000 | – | 119,775 | – | 0.71% | – |
| GBIO | New | GENERATION BIO CO | $289,000 | – | 10,738 | – | 0.05% | – |